DK1413305T3 - Aryl(eller heteroaryl)-azolylcarbinolderivater til behandling af urininkontinens - Google Patents

Aryl(eller heteroaryl)-azolylcarbinolderivater til behandling af urininkontinens

Info

Publication number
DK1413305T3
DK1413305T3 DK02745440T DK02745440T DK1413305T3 DK 1413305 T3 DK1413305 T3 DK 1413305T3 DK 02745440 T DK02745440 T DK 02745440T DK 02745440 T DK02745440 T DK 02745440T DK 1413305 T3 DK1413305 T3 DK 1413305T3
Authority
DK
Denmark
Prior art keywords
heteroaryl
aryl
treatment
urinary incontinence
azolylcarbinol
Prior art date
Application number
DK02745440T
Other languages
Danish (da)
English (en)
Inventor
Ramon Merce-Vidal
Blas Andaluz-Mataro
Jordi Frigola-Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Application granted granted Critical
Publication of DK1413305T3 publication Critical patent/DK1413305T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK02745440T 2001-07-06 2002-07-01 Aryl(eller heteroaryl)-azolylcarbinolderivater til behandling af urininkontinens DK1413305T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101587A ES2180449B1 (es) 2001-07-06 2001-07-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.

Publications (1)

Publication Number Publication Date
DK1413305T3 true DK1413305T3 (da) 2006-09-18

Family

ID=8498326

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02745440T DK1413305T3 (da) 2001-07-06 2002-07-01 Aryl(eller heteroaryl)-azolylcarbinolderivater til behandling af urininkontinens

Country Status (23)

Country Link
US (2) US20030022925A1 (ja)
EP (1) EP1413305B1 (ja)
JP (1) JP2004521150A (ja)
KR (1) KR20040030788A (ja)
CN (1) CN1543344A (ja)
AR (1) AR034679A1 (ja)
AT (1) ATE327752T1 (ja)
BR (1) BR0211237A (ja)
CA (1) CA2452646A1 (ja)
CY (1) CY1105113T1 (ja)
DE (1) DE60211913T2 (ja)
DK (1) DK1413305T3 (ja)
ES (2) ES2180449B1 (ja)
MA (1) MA27056A1 (ja)
MX (1) MXPA04000065A (ja)
NO (1) NO20040031L (ja)
NZ (1) NZ530817A (ja)
PL (1) PL369062A1 (ja)
PT (1) PT1413305E (ja)
RU (1) RU2308268C2 (ja)
UA (1) UA79238C2 (ja)
WO (1) WO2003004022A1 (ja)
ZA (1) ZA200400780B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
DE10335566A1 (de) * 2003-07-31 2005-02-24 Grünenthal GmbH Arzneimittel enthaltend Derivate von Aryl( oder Heteroaryl)azolylcarbinolen
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
EP1784178A1 (en) * 2004-07-30 2007-05-16 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
US20070021485A1 (en) * 2005-07-22 2007-01-25 Gomis Antonio F Aryl (or heteroaryl) azolylcarbinols
WO2007017127A2 (en) * 2005-07-29 2007-02-15 Laboratorios Del Dr. Esteve, S.A Controlled realease dosage form of pirazole compounds to treat urinary incontinence
US8722079B2 (en) 2008-04-18 2014-05-13 Warsaw Orthopedic, Inc. Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
US20100291151A1 (en) * 2009-04-21 2010-11-18 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE891865A (fr) * 1981-01-30 1982-07-22 Sandoz Sa Nouveaux medicaments a base de derives condenses de l'imidazole pour le traitement des troubles urinaires
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) * 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.

Also Published As

Publication number Publication date
UA79238C2 (en) 2007-06-11
DE60211913T2 (de) 2007-05-24
WO2003004022A1 (es) 2003-01-16
ES2180449B1 (es) 2004-01-16
RU2004103475A (ru) 2005-06-10
ES2263792T3 (es) 2006-12-16
AR034679A1 (es) 2004-03-03
NZ530817A (en) 2005-07-29
CN1543344A (zh) 2004-11-03
PL369062A1 (en) 2005-04-18
MXPA04000065A (es) 2004-05-21
EP1413305A1 (en) 2004-04-28
ZA200400780B (en) 2005-01-31
ATE327752T1 (de) 2006-06-15
DE60211913D1 (de) 2006-07-06
NO20040031L (no) 2004-03-02
MA27056A1 (fr) 2004-12-20
JP2004521150A (ja) 2004-07-15
ES2180449A1 (es) 2003-02-01
PT1413305E (pt) 2006-09-29
KR20040030788A (ko) 2004-04-09
US20050131049A1 (en) 2005-06-16
CA2452646A1 (en) 2003-01-16
EP1413305B1 (en) 2006-05-31
CY1105113T1 (el) 2010-03-03
US20030022925A1 (en) 2003-01-30
RU2308268C2 (ru) 2007-10-20
BR0211237A (pt) 2004-08-10

Similar Documents

Publication Publication Date Title
LTPA2020503I1 (lt) Rapamicino darinys, skirtas kasos vėžio gydymui
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1292594T3 (da) Quinazolinderivater til behandling af tumorer
DK1377556T3 (da) Pyrazolderivater til behandling af HIV
DK1438306T3 (da) Derivater af UK-2A
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1459749T3 (da) (S,S)-reboxetin til behandling af inkontinens
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
DK1413305T3 (da) Aryl(eller heteroaryl)-azolylcarbinolderivater til behandling af urininkontinens
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
DE60233718D1 (de) Wasserbasierendes hydrophobiermittel zur behandlung von substraten
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
IS6917A (is) Epóþílon afleiður til meðhöndlunar erfiðra æxla
DK1392318T3 (da) 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse
DK1150991T3 (da) Præparater til behandling af inflammatoriske reaktioner
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
DK1206436T3 (da) Retinoider til behandling af emfysem
DK1516596T3 (da) Forbedret system til behandling af stress-urinkontinens
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1434588T3 (da) 2-(amino-3,4-dioxo-1cyclobuten-1-yl)aminoalkylsyrederivater til behandling af smerte
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1282599T3 (da) Disulfidderivater, der er egnede til behandling af allergiske sygdomme